Practice question

Answer the question and get instant feedback.

ModerateEndocrinologyCardiometabolic therapy optimisationus-abimus-usmle-step-2

A 63-year-old man with T2DM (A1c 7.0%) and BMI 35 kg/m² wants to reduce CV risk. He is already on SGLT2 inhibitor. Next agent to add?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.